Indivior is a pharmaceutical company that focuses on the development and commercialization of medications for the treatment of opioid use disorder and other behavioral health issues. The company is committed to scientific research, innovation, and patient safety. Indivior actively involves itself in therapeutic development, external medical education, and corporate responsibility initiatives. It operates on a global scale, providing resources and support for healthcare professionals and patients. Indivior's notable product, SUBLOCADE®, is used in the treatment of opioid use disorder, emphasizing its role in recovery and healthcare advocacy.